222 related articles for article (PubMed ID: 8624711)
41. Reductions in body weight following chronic central opioid receptor subtype antagonists during development of dietary obesity in rats.
Cole JL; Leventhal L; Pasternak GW; Bowen WD; Bodnar RJ
Brain Res; 1995 Apr; 678(1-2):168-76. PubMed ID: 7620885
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of tuberoinfundibular dopaminergic neural activity during suckling: involvement of mu and kappa opiate receptor subtypes.
Callahan P; Baumann MH; Rabii J
J Neuroendocrinol; 1996 Oct; 8(10):771-6. PubMed ID: 8910807
[TBL] [Abstract][Full Text] [Related]
43. In vivo neurochemical evidence that delta1-, delta2- and mu2-opioid receptors, but not mu1-opioid receptors, inhibit acetylcholine efflux in the nucleus accumbens of freely moving rats.
Kiguchi Y; Aono Y; Watanabe Y; Yamamoto-Nemoto S; Shimizu K; Shimizu T; Kosuge Y; Waddington JL; Ishige K; Ito Y; Saigusa T
Eur J Pharmacol; 2016 Oct; 789():402-410. PubMed ID: 27445235
[TBL] [Abstract][Full Text] [Related]
44. Opioid receptor subtype antagonists differentially alter GABA agonist-induced feeding elicited from either the nucleus accumbens shell or ventral tegmental area regions in rats.
Khaimova E; Kandov Y; Israel Y; Cataldo G; Hadjimarkou MM; Bodnar RJ
Brain Res; 2004 Nov; 1026(2):284-94. PubMed ID: 15488491
[TBL] [Abstract][Full Text] [Related]
45. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
Solinas M; Goldberg SR
Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
[TBL] [Abstract][Full Text] [Related]
46. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats.
Negus SS; Henriksen SJ; Mattox A; Pasternak GW; Portoghese PS; Takemori AE; Weinger MB; Koob GF
J Pharmacol Exp Ther; 1993 Jun; 265(3):1245-52. PubMed ID: 8389859
[TBL] [Abstract][Full Text] [Related]
47. Interaction of cholecystokinin and somatostatin with a selective mu-opioid agonist and mu- and kappa-antagonists in thermoregulation.
Ghosh S; Geller EB; Adler MW
Brain Res; 1997 Jan; 745(1-2):152-7. PubMed ID: 9037404
[TBL] [Abstract][Full Text] [Related]
48. Anoretic effects of neuropeptide FF are mediated via central mu and kappa subtypes of opioid receptors and receptor ligands.
Cline MA; Mathews DS
Gen Comp Endocrinol; 2008; 159(2-3):125-9. PubMed ID: 18823989
[TBL] [Abstract][Full Text] [Related]
49. Mu-opioid receptor is involved in beta-endorphin-induced feeding in goldfish.
de Pedro N; Céspedes MV; Delgado MJ; Alonso-Bedate M
Peptides; 1996; 17(3):421-4. PubMed ID: 8735968
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of suckling-induced prolactin release by mu- and kappa-opioid antagonists.
Baumann MH; Rabii J
Brain Res; 1991 Dec; 567(2):224-30. PubMed ID: 1667901
[TBL] [Abstract][Full Text] [Related]
51. The first suckling episode in the rat: the role of endogenous activity at mu and kappa opioid receptors.
Petrov ES; Varlinskaya EI; Smotherman WP
Dev Psychobiol; 2000 Nov; 37(3):129-43. PubMed ID: 11044861
[TBL] [Abstract][Full Text] [Related]
52. Opiate agonists microinjected into the nucleus accumbens enhance sucrose drinking in rats.
Zhang M; Kelley AE
Psychopharmacology (Berl); 1997 Aug; 132(4):350-60. PubMed ID: 9298512
[TBL] [Abstract][Full Text] [Related]
53. Reversible suppression of food reward behavior by chronic mu-opioid receptor antagonism in the nucleus accumbens.
Shin AC; Pistell PJ; Phifer CB; Berthoud HR
Neuroscience; 2010 Oct; 170(2):580-8. PubMed ID: 20654704
[TBL] [Abstract][Full Text] [Related]
54. The dynamic relationship between mu and kappa opioid receptors in body temperature regulation.
Chen X; McClatchy DB; Geller EB; Tallarida RJ; Adler MW
Life Sci; 2005 Dec; 78(4):329-33. PubMed ID: 16257420
[TBL] [Abstract][Full Text] [Related]
55. Reductions in locomotor activity following central opioid receptor subtype antagonists in rats.
Leventhal L; Cole JL; Bodnar RJ
Physiol Behav; 1996 Sep; 60(3):833-6. PubMed ID: 8873259
[TBL] [Abstract][Full Text] [Related]
56. κ Opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake.
Whitfield TW; Schlosburg JE; Wee S; Gould A; George O; Grant Y; Zamora-Martinez ER; Edwards S; Crawford E; Vendruscolo LF; Koob GF
J Neurosci; 2015 Mar; 35(10):4296-305. PubMed ID: 25762676
[TBL] [Abstract][Full Text] [Related]
57. Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens.
Zhang M; Gosnell BA; Kelley AE
J Pharmacol Exp Ther; 1998 May; 285(2):908-14. PubMed ID: 9580643
[TBL] [Abstract][Full Text] [Related]
58. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
Liu-Chen LY; Yang HH; Li S; Adams JU
J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
[TBL] [Abstract][Full Text] [Related]
59. Mu-opioid receptor inhibition decreases voluntary wheel running in a dopamine-dependent manner in rats bred for high voluntary running.
Ruegsegger GN; Brown JD; Kovarik MC; Miller DK; Booth FW
Neuroscience; 2016 Dec; 339():525-537. PubMed ID: 27743985
[TBL] [Abstract][Full Text] [Related]
60. Involvement of opioid receptors in the oxytocin-induced antinociception in the central nervous system of rats.
Gao L; Yu LC
Regul Pept; 2004 Aug; 120(1-3):53-8. PubMed ID: 15177920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
